| Ms Cecelia F Jones, PHARMACIST | |
|
535 S 200 W, Bountiful, UT 84010-7213 | |
| (801) 298-9030 | |
| Not Available |
| Full Name | Ms Cecelia F Jones |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 535 S 200 W, Bountiful, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295954659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 140492-1701 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cecelia F Jones, PHARMACIST 543 Cleveland Ave, Salt Lake City, UT 84105-2026 Ph: (801) 483-1760 | Ms Cecelia F Jones, PHARMACIST 535 S 200 W, Bountiful, UT 84010-7213 Ph: (801) 298-9030 |
News Archive
A clinical trial of book reading to help kindergarten children with Specific Language Impairment learn words has determined the number of times a child with SLI needs to hear a word to learn it: that would be 36 times or exposures compared to 12 times for typically developing children.
Researchers at UC Santa Barbara have developed a new way to deliver drugs into cancer cells by exposing them briefly to a non-harmful laser. Their results are published in a recent article in ACS Nano, a journal of the American Chemical Society.
Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
› Verified 4 days ago
Dr. Jeffrey David Robinson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 W 500 S, Bountiful, UT 84010 Phone: 801-294-1907 | |
Kort H. Delost, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 E 500 S, Bountiful, UT 84010 Phone: 801-295-3463 Fax: 801-298-8223 | |
Scott Turpin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 573 W 100 N, Bountiful, UT 84010 Phone: 801-299-3968 Fax: 801-299-3965 | |
Christopher James Buckel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 555 S 200 W, Bountiful, UT 84010 Phone: 801-397-7833 | |
Meiqi Jiang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 S 500 W, Bountiful, UT 84010 Phone: 801-294-9107 | |
Dr. Clara Jaklyn Ashton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1507 N 150 W, Bountiful, UT 84010 Phone: 801-635-9367 | |
Jason Chan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 261 S Moss Hill Dr, Bountiful, UT 84010 Phone: 801-840-4350 Fax: 801-840-4357 |